Edwards Lifesciences Corporation (EW)

88,17 -0,44 (-0,50%) In data: 01:25PM EDT. Mercato aperto.

Edwards Lifesciences Corporation

One Edwards Way
Irvine, CA 92614
United States
949 250 2500
https://www.edwards.com

Settore/i: Healthcare
Settore: Medical Devices
Impiegati a tempo pieno: 19.800

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Bernard J. Zovighian	CEO & Director	2,27M	N/D	1968
Mr. Scott B. Ullem	Corporate VP & CFO	1,35M	6,36M	1967
Mr. Donald E. Bobo Jr.	Corporate Vice President of Strategy & Corporate Development	1,27M	2,68M	1962
Mr. Larry L. Wood	Corporate VP and Group President of TAVR & Surgical Structural Heart	1,49M	2,13M	1966
Dr. Todd J. Brinton FACC, M.D.	Corporate VP of Advanced Technology & Chief Scientific Officer	N/D	N/D	N/D
Mark Wilterding	Vice President of Investor Relations	N/D	N/D	N/D
Mr. Arnold A. Pinkston	Corporate VP & General Counsel	N/D	N/D	1959
Mr. Dirksen J. Lehman	Corporate Vice President of Public Affairs	N/D	N/D	N/D
Ms. Christine Z. McCauley	Corporate Vice President of Human Resources	N/D	N/D	1965
Mr. Gary I. Sorsher	Senior Vice President of Quality & Regulatory Compliance	N/D	N/D	1965

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Governance aziendale

L'ISS Governance QualityScore di Edwards Lifesciences Corporation al 1 aprile 2024 è 3. I criteri di valutazione fondamentali sono revisione: 4; Consiglio di Amministrazione: 5; diritti degli azionisti: 4; retribuzione: 3.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.